Tipping the balance towards tolerance: The basis for therapeutic immune modulation by gold?

References

• Schuppe HC, Ronnau AC, von Schmiedeberg S, Ruzicka T, Gleichmann E, Griem P. Immunomodulation by heavy metal compounds. Clin Dermatol 1998; 16: 149–157
   PubMedGoogle Scholar
• Layland LE, Wulferink M, Dierkes S, Gleichmann E. Drug-induced autoantibody formation in mice: Triggering by primed CD4+CD25 − T-cells, prevention by primed CD4+CD25+ T-cells. Eur J Immunol 2004; 34: 36–46
   PubMed Web of Science ®Google Scholar
• Albers R, Broeders A, van der Pijl A, Seinen W, Pieters R. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals. Toxicol Appl Pharmacol 1997; 143: 102–109
   PubMed Web of Science ®Google Scholar
• Pieters R, Ezendam J, Bleumink R, Bol M, Nierkens S. Predictive testing for autoimmunity. Toxicol Lett 2002; 127: 83–91
   PubMed Web of Science ®Google Scholar
• Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 2000; 176: 154–170
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111–119
   PubMed Web of Science ®Google Scholar
• Piccirillo CA, Shevach EM. Naturally-occurring CD4+CD25+ immunoregulatory T-cells: Central players in the arena of peripheral tolerance. Semin Immunol 2004; 16: 81–88
   PubMed Web of Science ®Google Scholar
• Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737–742
   PubMed Web of Science ®Google Scholar
• Groux H. Type 1 T-regulatory cells: Their role in the control of immune responses. Transplantation 2003; 75: 8S–12S
   PubMed Web of Science ®Google Scholar
• Toussirot EA. Oral tolerance in the treatment of rheumatoid arthritis. Curr Drug Targets Inflamm Allergy 2002; 1: 45–52
   PubMedGoogle Scholar
• O'Garra A, Vieira P. Regulatory T-cells and mechanisms of immune system control. Nat Med 2004; 10: 801–805
   PubMed Web of Science ®Google Scholar
• O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J Clin Investig 2004; 114: 1372–1378
   PubMed Web of Science ®Google Scholar
• Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, et al. Induction of IL-10-producing CD4+CD25+ T-cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res Ther 2004; 6: R213–R219
   PubMed Web of Science ®Google Scholar
• Pecanha LM, Snapper CM, Lees A, Mond JJ. Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5- but not IL-2-induced Ig secretion by T-cell-independent antigens. J Immunol 1992; 148: 3427–3432
   PubMedGoogle Scholar
• Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666–668
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765
   PubMed Web of Science ®Google Scholar
• Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T-lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Investig Dermatol 2000; 114: 295–302
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Regulatory T-cells in the control of immune pathology. Nat Immunol 2001; 2: 816–822
   PubMed Web of Science ®Google Scholar
• Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y. Regulatory T-cells and organ transplantation. Semin Immunol 2004; 16: 119–126
   PubMed Web of Science ®Google Scholar
• Tung KS, Agersborg SS, Alard P, Garza KM, Lou YH. Regulatory T-cell, endogenous antigen and neonatal environment in the prevention and induction of autoimmune disease. Immunol Rev 2001; 182: 135–148
   Google Scholar
• Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137–161
   PubMed Web of Science ®Google Scholar
• Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999; 26: 717–719
   PubMed Web of Science ®Google Scholar
• Toussirot E, Wendling D. The use of TNF-alpha blocking agents in rheumatoid arthritis: An overview. Expert Opin Pharmacother 2004; 5: 581–594
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: A renewed sense of self. Science 2002; 296: 301–305
   PubMed Web of Science ®Google Scholar
• Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T-cells. J Exp Med 1996; 184: 19–29
   PubMed Web of Science ®Google Scholar
• Mulherin DM, Struthers GR, Situnayake RD. Do gold rings protect against articular erosion in rheumatoid arthritis?. Ann Rheum Dis 1997; 56: 497–499
   PubMedGoogle Scholar
• Hernandez-Trujillo VP, Lieberman PL, Chowdhury BA. Drug allergens, haptens, and anaphylatoxins. Clin Allergy Immunol 2004; 18: 387–419
   PubMedGoogle Scholar
• Berges-Gimeno MP, Stevenson DD. Nonsteroidal anti-inflammatory drug-induced reactions and desensitization. J Asthma 2004; 41: 375–384
   PubMed Web of Science ®Google Scholar
• Dayan AD. Immunotoxicity of metals and immunotoxicology. Plenum Press, New York 1990; 317, International Programme on Chemical Safety, IPCS joint symposia; no. 15
   Google Scholar
• Gutting BW, Bouzahzah F, Kong PL, Updyke LW, Amacher DE, Craft J. Oxazolone and diclofenac-induced popliteal lymph node assay reactions are attenuated in mice orally pretreated with the respective compound: Potential role for the induction of regulatory mechanisms following enteric administration. Toxicol Appl Pharmacol 2003; 189: 120–133
   PubMedGoogle Scholar
• Hisaeda H, Maekawa Y, Iwakawa D, Okada H, Himeno K, Kishihara K, et al. Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T-cells. Nat Med 2004; 10: 29–30
   PubMed Web of Science ®Google Scholar
• Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, et al. IL-10-producing T-cells suppress immune responses in anergic tuberculosis patients. J Clin Investig 2000; 105: 1317–1325
   PubMed Web of Science ®Google Scholar
• Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999; 59: 3128–3133
   PubMed Web of Science ®Google Scholar
• Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T-cells: A common basis between tumor immunity and autoimmunity. J Immunol 1999; 163: 5211–5218
   PubMed Web of Science ®Google Scholar
• Golgher D, Jones E, Powrie F, Elliott T, Gallimore A. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002; 32: 3267–3275
   PubMed Web of Science ®Google Scholar